Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 94

1.

Possible leukemogenic potential of temozolomide.

Weiss B, Geiger H, Davies SM.

Pediatr Blood Cancer. 2009 Apr;52(4):553. doi: 10.1002/pbc.21865. No abstract available.

PMID:
19058212
[PubMed - indexed for MEDLINE]
2.

Non-Hodgkin's lymphoma in patients with glioma treated with temozolomide.

Neyns B, Cordera S, Joosens E, Pouratian N.

J Clin Oncol. 2008 Sep 20;26(27):4518-9. doi: 10.1200/JCO.2008.18.8177. No abstract available. Erratum in: J Clin Oncol. 2009 Jun 20;27(18):3070. Nader, Pouratian [corrected to Pouratian, Nader].

PMID:
18802168
[PubMed - indexed for MEDLINE]
Free Article
3.

Mutagenic potential of temozolomide in bone marrow cells in vivo.

Geiger H, Schleimer D, Nattamai KJ, Dannenmann SR, Davies SM, Weiss BD.

Blood. 2006 Apr 1;107(7):3010-1. No abstract available.

PMID:
16554488
[PubMed - indexed for MEDLINE]
Free Article
4.

Non-Hodgkin lymphoma following temozolomide.

Sharma A, Gupta D, Mohanti BK, Thulkar S, Dwary A, Goyal S, Muzumder S, Das P.

Pediatr Blood Cancer. 2009 Oct;53(4):661-2. doi: 10.1002/pbc.22090.

PMID:
19533661
[PubMed - indexed for MEDLINE]
5.

Hemorrhagic cystitis as an unexpected adverse reaction to temozolomide: case report.

Islam R, Isaacson BJ, Zickerman PM, Ratanawong C, Tipping SJ.

Am J Clin Oncol. 2002 Oct;25(5):513-4.

PMID:
12393995
[PubMed - indexed for MEDLINE]
6.

Temozolomide may induce therapy-related acute lymphoblastic leukaemia.

Ogura M, Todo T, Tanaka M, Nannya Y, Ichikawa M, Nakamura F, Kurokawa M.

Br J Haematol. 2011 Sep;154(5):663-5. doi: 10.1111/j.1365-2141.2011.08641.x. Epub 2011 Apr 26. Review. No abstract available.

PMID:
21518332
[PubMed - indexed for MEDLINE]
7.

[Phototoxicity of dacarbazine (Deticene) not reinduced by temozolomide (Temodal)].

Schmutz JL, Barbaud A, Trechot P.

Ann Dermatol Venereol. 2006 May;133(5 Pt 1):500. French. No abstract available.

PMID:
16760848
[PubMed - indexed for MEDLINE]
8.

The translesion polymerase Rev3L in the tolerance of alkylating anticancer drugs.

Roos WP, Tsaalbi-Shtylik A, Tsaryk R, G├╝vercin F, de Wind N, Kaina B.

Mol Pharmacol. 2009 Oct;76(4):927-34. doi: 10.1124/mol.109.058131. Epub 2009 Jul 29.

PMID:
19641035
[PubMed - indexed for MEDLINE]
Free Article
9.

[Treatment of glioma with temozolomide].

Nishikawa R.

Brain Nerve. 2009 Jul;61(7):849-54. Review. Japanese.

PMID:
19618863
[PubMed - indexed for MEDLINE]
10.

Temozolomide for melanoma: new toxicities and new opportunities.

Gajewski TF.

J Clin Oncol. 2004 Feb 15;22(4):580-1. Epub 2004 Jan 15. No abstract available.

PMID:
14726506
[PubMed - indexed for MEDLINE]
Free Article
11.

Another cause of pancytopenia in a patient receiving temozolomide.

Pehlivan Y, Sevinc A, Turkbeyler IH, Dirier A, Kalender ME, Camci C.

Med Princ Pract. 2011;20(4):377-9. doi: 10.1159/000324800. Epub 2011 May 11.

PMID:
21577001
[PubMed - indexed for MEDLINE]
12.

Temozolomide in malignant gliomas: current use and future targets.

Villano JL, Seery TE, Bressler LR.

Cancer Chemother Pharmacol. 2009 Sep;64(4):647-55. doi: 10.1007/s00280-009-1050-5. Epub 2009 Jun 19. Review.

PMID:
19543728
[PubMed - indexed for MEDLINE]
13.

MSH6 inactivation and emergent temozolomide resistance in human glioblastomas.

Cahill DP, Codd PJ, Batchelor TT, Curry WT, Louis DN.

Clin Neurosurg. 2008;55:165-71. No abstract available.

PMID:
19248684
[PubMed - indexed for MEDLINE]
14.

Successful treatment of palmar-plantar erythrodysesthesia possibly due to temozolomide with dexamethasone.

Kanat O, Baskan BE, Kurt E, Evrensel T.

J Postgrad Med. 2007 Apr-Jun;53(2):146. No abstract available.

PMID:
17495388
[PubMed - indexed for MEDLINE]
Free Article
15.

Disseminated salmonellosis in a patient treated with temozolomide.

Georgescu G, Isola IM, Youssef S, Adachi J, Rolston K.

J Infect. 2008 Nov;57(5):414-5. doi: 10.1016/j.jinf.2008.06.021. Epub 2008 Aug 19.

PMID:
18715650
[PubMed - indexed for MEDLINE]
16.

Long-term use of temozolomide: could you use temozolomide safely for life in gliomas?

Khasraw M, Bell D, Wheeler H.

J Clin Neurosci. 2009 Jun;16(6):854-5. doi: 10.1016/j.jocn.2008.09.005. Epub 2009 Mar 20.

PMID:
19303779
[PubMed - indexed for MEDLINE]
17.

IDH1 mutations in low-grade astrocytomas predict survival but not response to temozolomide.

Dubbink HJ, Taal W, van Marion R, Kros JM, van Heuvel I, Bromberg JE, Zonnenberg BA, Zonnenberg CB, Postma TJ, Gijtenbeek JM, Boogerd W, Groenendijk FH, Smitt PA, Dinjens WN, van den Bent MJ.

Neurology. 2009 Nov 24;73(21):1792-5. doi: 10.1212/WNL.0b013e3181c34ace.

PMID:
19933982
[PubMed - indexed for MEDLINE]
18.

Modulation of the efficacy of temozolomide and dacarbazine melanoma treatment by DNA-repair factors in vivo and in vitro.

Boeckmann L, Thoms KM, Gutzmer R, Has C, Kunz M, Kuschal C, Laspe P, Struever D, Emmert S.

Int J Clin Pharmacol Ther. 2009 Jan;47(1):33-5. No abstract available.

PMID:
19203531
[PubMed - indexed for MEDLINE]
19.

The safety of temozolomide in the treatment of malignancies.

Trinh VA, Patel SP, Hwu WJ.

Expert Opin Drug Saf. 2009 Jul;8(4):493-9. doi: 10.1517/14740330902918281 . Review.

PMID:
19435405
[PubMed - indexed for MEDLINE]
20.

Clinical utility of temozolomide in the treatment of malignant paraganglioma: a preliminary report.

Bravo EL, Kalmadi SR, Gill I.

Horm Metab Res. 2009 Sep;41(9):703-6. doi: 10.1055/s-0029-1224135. Epub 2009 Jun 17.

PMID:
19536732
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk